Oncology Central

From traditional to whole-genome sequencing biomarkers for gastric cancer


Despite advances in traditional research and identification of important single genes such as CDH1, personalized treatment of gastric cancer is still in its infancy. In this editorial, we summarize the potential and challenges of comprehensive high-throughput analyses, including whole-genome sequencing (WGS) and microarrays-based gene expression profiling in clinical samples. Such a revolutionary strategy can lead to the discovery of next-generation biomarkers for gastric cancer.

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.




News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.